GENPHARMASEC
|
The Current P/E Ratio of GENPHARMASEC is -53.60.
| Share Price | ₹1.0 | Mar 16,2026 |
| Market Cap | ₹57.0 Cr | |
| Earnings-TTM | ₹-1.1 Cr | TTM-Consolidated Results |
| Price/Earnings | -53.60x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of GENPHARMASEC
Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹57.0 Cr] as on Mar 16,2026
(/) Earnings [ ₹-1.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -53.60x ]
P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.
Thus, for GENPHARMASEC , the investors are currently willing to pay -53.60 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.
Thus, for GENPHARMASEC , the investors are currently willing to pay -53.60 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.
Historical PE (Price/Earnings) ratio chart of GENPHARMASEC
PE Ratio Performance Analysis for GENPHARMASEC
- GENPHARMASEC 's latest p/e ratio is -53.60x.
- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 43.09x.
- GENPHARMASEC 's operated at median p/e ratio of 46x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2025 at 83.26x.
- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2024 of 0x.
- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 43.09x.
- GENPHARMASEC 's operated at median p/e ratio of 46x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2025 at 83.26x.
- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does GENPHARMASEC 's P/E Ratio benchmark against top 10 peers in Dyes & Pigments Industry?
| Peer Comparison (Dyes & Pigments Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| GENPHARMASEC | -1.06 | -53.60 | 57.0 |
| SUDARSHAN CHEMICAL INDUSTRIES LTD | -68.15 | -92.38 | 6,296.0 |
| KIRI INDUSTRIES LTD | 4,817.06 | 0.48 | 2,292.0 |
| VIDHI SPECIALTY FOOD INGREDIENTS LTD | 47.57 | 30.22 | 1,437.7 |
| SHREE PUSHKAR CHEMICALS & FERTILISERS LTD | 73.77 | 12.99 | 958.7 |
| BODAL CHEMICALS LTD | 30.27 | 18.07 | 547.0 |
| BHAGERIA INDUSTRIES LTD | 48.31 | 12.77 | 617.1 |
| DYNEMIC PRODUCTS LTD | 17.81 | 14.29 | 254.5 |
| PODDAR PIGMENTS LTD | 15.16 | 15.13 | 229.3 |
| ASAHI SONGWON COLORS LTD | 13.83 | 16.08 | 222.5 |
| JAYSYNTH ORGOCHEM LTD | 12.06 | 12.98 | 156.5 |
Dyes & Pigments Industry Benchmark (Top 10) PE Analysis vs GENPHARMASEC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -92.38x |
| Max industry PE | 30.22x |
| Median industry PE | 12.99x |
| Average industry PE | -1.18x |
You may also like the below Video Courses
